These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24501218)

  • 21. Learning from mouse models of MLL fusion gene-driven acute leukemia.
    Schwaller J
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
    Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
    Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
    Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG
    Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathogenesis of disease progression in MLL-rearranged AML.
    Kotani S; Yoda A; Kon A; Kataoka K; Ochi Y; Shiozawa Y; Hirsch C; Takeda J; Ueno H; Yoshizato T; Yoshida K; Nakagawa MM; Nannya Y; Kakiuchi N; Yamauchi T; Aoki K; Shiraishi Y; Miyano S; Maeda T; Maciejewski JP; Takaori-Kondo A; Ogawa S; Makishima H
    Leukemia; 2019 Mar; 33(3):612-624. PubMed ID: 30209403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).
    Stubbs MC; Krivtsov AV
    Curr Protoc Pharmacol; 2017 Sep; 78():14.42.1-14.42.19. PubMed ID: 28892146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.
    Ghisi M; Kats L; Masson F; Li J; Kratina T; Vidacs E; Gilan O; Doyle MA; Newbold A; Bolden JE; Fairfax KA; de Graaf CA; Firth M; Zuber J; Dickins RA; Corcoran LM; Dawson MA; Belz GT; Johnstone RW
    Cancer Cell; 2016 Jul; 30(1):59-74. PubMed ID: 27374225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia.
    Itskovich SS; Gurunathan A; Clark J; Burwinkel M; Wunderlich M; Berger MR; Kulkarni A; Chetal K; Venkatasubramanian M; Salomonis N; Kumar AR; Lee LH
    Nat Commun; 2020 May; 11(1):2369. PubMed ID: 32398749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.
    Li BE; Ernst P
    Exp Hematol; 2014 Dec; 42(12):995-1012. PubMed ID: 25264566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
    Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
    Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
    Zhang S; Lu Y; Jiang C
    J Recept Signal Transduct Res; 2020 Aug; 40(4):339-347. PubMed ID: 32122211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
    Li H; Mar BG; Zhang H; Puram RV; Vazquez F; Weir BA; Hahn WC; Ebert B; Pellman D
    Blood; 2017 Jan; 129(4):497-508. PubMed ID: 27756750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes.
    Fleischmann KK; Pagel P; Schmid I; Roscher AA
    Mol Cancer; 2014 Feb; 13():27. PubMed ID: 24517546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
    Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R
    Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.
    Yoshihama Y; LaBella KA; Kim E; Bertolet L; Colic M; Li J; Shang X; Wu CJ; Spring DJ; Wang YA; Hart T; DePinho RA
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34475205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chromatin-remodeling factor
    Heshmati Y; Türköz G; Harisankar A; Kharazi S; Boström J; Dolatabadi EK; Krstic A; Chang D; Månsson R; Altun M; Qian H; Walfridsson J
    Haematologica; 2018 Jul; 103(7):1169-1181. PubMed ID: 29599201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
    Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.
    Cheung N; Fung TK; Zeisig BB; Holmes K; Rane JK; Mowen KA; Finn MG; Lenhard B; Chan LC; So CW
    Cancer Cell; 2016 Jan; 29(1):32-48. PubMed ID: 26766589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
    Chen L; Chen W; Mysliwski M; Serio J; Ropa J; Abulwerdi FA; Chan RJ; Patel JP; Tallman MS; Paietta E; Melnick A; Levine RL; Abdel-Wahab O; Nikolovska-Coleska Z; Muntean AG
    Leukemia; 2015 Jun; 29(6):1290-300. PubMed ID: 25650089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.